CVR number 14702687
Industry 32.5000 Manufacture of medical and dental instruments and supplies

KRØLLS DENTALLABORATORIUM KØGE ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  10.1% 15.8% 12.4% 10.3% 14.8%  
Credit score (0-100)  26 12 18 23 13  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  -0.0 0.0 0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  1.2 -3.5 -3.5 -3.5 -2.2  
EBITDA  1.2 -3.5 -3.5 -3.5 -2.2  
EBIT  1.2 -3.5 -3.5 -3.5 -2.2  
Pre-tax profit (PTP)  0.9 -3.8 -4.1 -4.2 -3.2  
Net earnings  0.9 18.0 -4.1 -4.2 -3.2  
Pre-tax profit without non-rec. items  0.9 -3.8 -4.1 -4.2 -3.2  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -11.4 6.5 2.5 -1.8 -5.0  
Interest-bearing liabilities  11.2 12.8 21.2 2.9 2.9  
Balance sheet total (assets)  2.2 21.8 26.3 3.8 0.6  
Net Debt  8.9 12.8 16.6 -0.9 2.3  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1.2 -3.5 -3.5 -3.5 -2.2  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 36.1%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2 22 26 4 1  
Balance sheet change%  -11.9% 876.6% 20.9% -85.5% -83.5%  
Added value  1.2 -3.5 -3.5 -3.5 -2.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  8.7% -19.7% -14.5% -21.9% -40.0%  
ROI %  13.6% -23.0% -16.3% -26.4% -77.4%  
ROE %  39.4% 410.2% -90.4% -134.3% -143.3%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -83.7% 30.0% 9.4% -31.5% -88.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  722.4% -364.3% -474.9% 26.8% -101.0%  
Gearing %  -97.7% 195.0% 858.6% -164.0% -58.3%  
Net interest  0 0 0 0 0  
Financing costs %  3.3% 2.5% 3.4% 6.1% 33.2%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.2 1.4 1.1 0.7 0.1  
Current Ratio  0.2 1.4 1.1 0.7 0.1  
Cash and cash equivalent  2.2 0.0 4.6 3.8 0.6  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -11.4 6.5 2.5 -1.8 -5.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0